Alpha Fusion Inc.

Alpha Fusion Inc.

Private
TokyoHealthcare & Life Scienceshttps://alpha-fusion.com

Last Round

Series B

Oct 9, 2024

Total Funding Raised

$11.12M

Company Overview

Alpha Fusion Inc. is a biotechnology company developing targeted alpha therapy (TAT) using astatine-211 for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

targeted alpha therapyTATastatine-211radiopharmaceuticals211Atcancer treatmentalpha emitterradioligand therapyprecision oncologyradiopharmaceutical therapydrug discoveryclinical trialsisotope supply chainoncology drug pipelinethyroid cancer therapyprostate cancer therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alpha Fusion Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alpha Fusion Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BOct 9, 2024
Series AMar 8, 2023

Alpha Fusion Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 8, 2025

    Collaborating with Kobe City Medical Center General Hospital on an At-211 investigational drug supply system.

Alpha Fusion Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alpha Fusion Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alpha Fusion Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range8
Year Founded2021
Last FundingOct 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.